replicateBE
Average Bioequivalence with Expanding Limits (ABEL)
Performs comparative bioavailability calculations for Average Bioequivalence with Expanding Limits (ABEL). Implemented are 'Method A' / 'Method B' and the detection of outliers. If the design allows, assessment of the empiric Type I Error and iteratively adjusting alpha to control the consumer risk. Average Bioequivalence - optionally with a tighter (narrow therapeutic index drugs) or wider acceptance range (South Africa: Cmax) - is implemented as well.
Versions across snapshots
| Version | Repository | File | Size |
|---|---|---|---|
1.1.3 |
rolling linux/jammy R-4.5 | replicateBE_1.1.3.tar.gz |
488.8 KiB |
1.1.3 |
rolling linux/noble R-4.5 | replicateBE_1.1.3.tar.gz |
488.8 KiB |
1.1.3 |
rolling source/ R- | replicateBE_1.1.3.tar.gz |
289.9 KiB |
1.1.3 |
latest linux/jammy R-4.5 | replicateBE_1.1.3.tar.gz |
488.8 KiB |
1.1.3 |
latest linux/noble R-4.5 | replicateBE_1.1.3.tar.gz |
488.8 KiB |
1.1.3 |
latest source/ R- | replicateBE_1.1.3.tar.gz |
289.9 KiB |
1.1.3 |
2026-04-26 source/ R- | replicateBE_1.1.3.tar.gz |
289.9 KiB |
1.1.3 |
2026-04-23 source/ R- | replicateBE_1.1.3.tar.gz |
289.9 KiB |
1.1.3 |
2026-04-09 windows/windows R-4.5 | replicateBE_1.1.3.zip |
507.3 KiB |
1.1.3 |
2025-04-20 source/ R- | replicateBE_1.1.3.tar.gz |
289.9 KiB |